Regularized Mixture Cure Models Identify a Gene Signature that Improves Risk Stratification Within the Favorable-Risk Group in 2017 European LeukemiaNet (ELN) Classification of Acute Myeloid Leukemia (Alliance)
   Google Scholar   
Citation:
Blood vol 140 (suppl 1) 1913-4
Meeting Instance:
ASH 2022
Year:
2022
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
4338  
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171  
Corr. Author:
 
Authors:
                   
Networks:
LAPS-IL057, LAPS-MO011, LAPS-OH007, OH070   
Study
Alliance-A152010
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-8721, CALGB-10503, CALGB-10603, CALGB-20202, CALGB-19808, CALGB-8461, CALGB-8525, CALGB-9222, CALGB-9621
Phases:
N/A, 1, 2, 3, N/A
Keywords:
AML, Prognosis, Transcriptome, mixture cure models, ELN Favorable